Inhibiting phosphorylation of the oncogenic PAX3-FOXO1 reduces alveolar rhabdomyosarcoma phenotypes identifying novel therapy options.

Loupe, J M; Miller, P J; Ruffin, D R; Stark, M W; Hollenbach, A D

Loupe, J M; Miller, P J; Ruffin, D R; Stark, M W; Hollenbach, A D.

Afiliación

Loupe JM; Louisiana State University Health Sciences Center, Department of Genetics, New Orleans, LA, USA.
Miller PJ; Louisiana State University Health Sciences Center, Department of Genetics, New Orleans, LA, USA.
Ruffin DR; Department of Pathology, Children's Hospital, New Orleans, LA, USA.
Stark MW; Department of Pathology, Children's Hospital, New Orleans, LA, USA.
Hollenbach AD; Louisiana State University Health Sciences Center, Department of Genetics, New Orleans, LA, USA.

Oncogenesis ; 4: e145, 2015 Mar 30.

Article en En | MEDLINE | ID: mdl-25821947

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncogenesis Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google